1.Progress of treatment of colon cancer with integrated traditional Chinese and western Medicine
Lingchang LI ; Jiege HUO ; Xiaoning WANG
International Journal of Traditional Chinese Medicine 2010;32(6):550-552
The authors stated post-operative adjuvant therapy, combined chemotherapy, and palliative treatment for colorectal cancer, trying to summarize progress of the treatment of colorectal cancer with integrated traditional Chinese and western medicine, researching the mechanism of action. The authors also presented their arguments.
2.Effect of Cluster Needling at Scalp Acupoints on the Contents of Hs-CRP and Homocysteine in Patients with Acute Cerebral Infarction
Xiaoning LI ; Huixia HUO ; Zhimin GUAN ; Shuangling LIU ; Huihui LIU
Shanghai Journal of Acupuncture and Moxibustion 2014;(10):885-887
Objective To observe the contents of hypersensitive C-reactive protein (hs-CRP) and homocysteine before and after cluster needling at scalp acupoints in patients with acute cerebral infarction, and to discuss its significance in clinic. Method Sixty patients with acute cerebral infarction were randomized into a treatment group and a control group, 30 in each group. The control group was intervened by regular medication, while the treatment group was intervened by cluster needling at scalp acupoints in addition to the treatment given to the control group. The contents of serum hs-CRP and homocysteine were observed before and after intervention, to objectively evaluate the cluster needling at scalp acupoints in patients with acute cerebral infarction. Result The contents of serum hs-CRP and homocysteine were significantly changed after intervention in both groups (P<0.05); there were significant differences in comparing the contents of serum hs-CRP and homocysteine between the two groups after intervention (P<0.01). Conclusion Cluster needling at scalp acupoints can decline the contents of hs-CRP and homocysteine in patients with acute cerebral infarction.
3.Gerder differences of coronary heart disease secondary prevention in patients post percutaneous ;coronary intervention
Xiaoning HAN ; Jie JIANG ; Yan ZHANG ; Ronghui YU ; Yanjun GONG ; Tao HONG ; Yong HUO
Chinese Journal of Interventional Cardiology 2014;(3):137-140
Objective To investigate the gender differences of coronary heart disease secondary prevention status in patients post percutaneous coronary intervention (PCI). Methods Patients diagnosed with coronary heart disease from 31 tertiary hospitals were enrolled for a baseline survey. Medical history and laboratory tests were taken. Analysis was done for outpatient or inpatient with the history of at least one PCI treatment. Status of smoking cessation, weight management, blood pressure < 140/90 mm Hg, low-density lipoprotein cholesterol (LDL-C) < 100 mg/dL (2.6 mmol/L), and use of antiplatlet drugs, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARB) and statins were collected and compared. Results Women (n=1151) accounted for 25.4% of all PCI patients (n=4532). Proportion of female with history of smoking was signiifcantly lower than male, but the proportion of quitting was similar between female and male, 53%(n=98) vs. 53.7%(n=1344), P=0.849. The average body mass index, mean waist circumference and proportion of overweight were higher in man than women, P=0.000. However, the proportion of abdominal obesity in women is higher than men, 75.2%vs. 52.8%, P=0.000. More female were comorbid with hypertension, hyperlipidemia and diabetes than male and the differences were signiifcant, P=0.000. Control rate of blood pressure, LDL-C and fasting glucose were lower in women than in man, the differences were 66.2% vs 73.4% for blood pressure, 47.8%vs. 57.0%for LDL-C and 57.5%vs. 62.7%for fasting glucose, P=0.000. There was no signiifcant difference in medication usage between different genders. Conclusions In patients post pecutaneous coronary intervention, female patients had more risk factors than male while risk factor control rate was lower comparing with male. Medication usage for coronary heart disease secondary prevention was similar between different genders.
4.An analysis of clinical factors for coronary artery calcification score
Huinan ZHU ; Yong HUO ; Jing ZHOU ; Hailiang WEI ; Lin TONG ; Songyun CHU ; Xiaoning HAN
Chinese Journal of Internal Medicine 2009;48(4):287-290
Objective To evaluate the correlating clinical factors of coronary artery calcification score(CACS).Methods 141 patients suspected of coronary artery disease were included.They underwent multi-slice row computed tomography,pulse wave velocity ( PWV ),UCG and blood biochemistry within a period of 3 months.The subjects were divided into three groups according to CAC score:A(CACS =0-10),B ( CACS = 11-400),C ( CACS > 400).Results CACS was significantly associated with age,history of hypertension and diabetes mellitus.It was also associated with the presence of mitral annular calcification and aortic valve calcification,low ankel brachial pressure index(ABI) and high mean artery pressure(MAP) as well as high values of brachial ankel PWV (baPWV) and Upstroke time (UT).Muhifactorial logistic regression analysis showed that the presence of aortic valve calcification and mitral annular calcification,the history of diabetes mellitus and high value of UT were independently correlated with severe coronary artery calcification.Conclusions Aortic valve calcification,mitral annular calcification,history of diabetes mellitus,high value of UT were independently correlated with severe coronary artery calcification.Measurement of PWV and UCG should be performed before muhi-slicerow computed tomography,because the assessment of coronary artery lumen narrowing with multi-slice row computed tomography can not be carried out accurately in the presence of severe coronary artery calcification.
5.Diagnostic value of combined detection of VEGF, SAA and hs-CRP for acute cerebral infarction
Shuang QIN ; Dou HUO ; Ruiqing XING ; Xiaoning ZHANG ; Yongchang WU ; Huiyu CHEN ; Daorong PENG
International Journal of Laboratory Medicine 2019;40(2):222-225
Objective To investigate the correction between the levels of vascular endothelial growth factor (VEGF), serum amyloid A (SAA), hypersensitive C-reactive protein (hs-CRP) and acute cerebral infarction (ACI), and to provide the basis for the diagnosis and treatment of ACI.Methods A total of 76patients with ACI in the hospital from August to October 2017were selected as ACI group.In addition, 32healthy subjects underwent physical examination in the same period in this hospital were selected as negative control group (NC group).The levels of SAA and hs-CRP were detected by nephelometry, while the level of VEGF was measured by enzyme-linked immunosorbent assay (ELISA).The differences of detection indexes between two groups were compared, and the diagnostic value of each index and the combined test were evaluated with the Youden index.Results The levels of SAA, hs-CRP and VEGF in ACI group, were significantly higher than those of NC group (P<0.01).The levels of VEGF was positively correlated with SAA and hs-CRP (r=0.434and0.631, P=0.000and 0.000).The optimal diagnostic critical points of VEGF, SAA and hs-CRP in the diagnosis of ACI were 161.93pg/mL, 3.81mg/L and 4.63mg/L, and the sensitivities were 93.55%, 65.91%and64.44%, the specificities were 60.00%, 93.75%and 90.32%, respectively.Combined detection with hs-CRP and VEGF was superior to single index detection and other joint detection.The sensitivity, specificity and Youden index of combined detection with hs-CRP and VEGF were 96.67%, 95.65%and 0.92respectively.Conclusion The levels of VEGF, SAA and hs-CRP increase in patients with ACI, and they play important roles in the diagnosis of ACI.VEGF are positively related to SAA and hs-CRP, and there may be an synergistic effect exist.VEGF may be involved in the pathological process of cerebral infarction.The combined detection of hs-CRP and VEGF is of high clinical value in the diagnosis of cerebral infarction.
6.Efficacy of community rehabilitation combined with drug therapy on patients with schizophrenia in rural communities
Chunyan WEI ; Jinmei YANG ; Dongrong ZHAO ; Yawen ZHU ; Xiaoning HUO ; Chao WANG
Sichuan Mental Health 2021;34(1):64-68
ObjectiveTo study the efficacy of community rehabilitation combined with drug therapy on rehabilitation of patients with schizophrenia in rural communities, and to provide references for community rehabilitation of patients with schizophrenia in rural areas of our country. MethodA total of 81 patients in rural communities of three towns in Lanzhou new area who met the diagnostic criteria of International Classification of Diseases, tenth edition (ICD-10) were randomly divided into study group (n=39) and control group (n=42). Both groups received general drug treatment. On this basis, the study group received community rehabilitation intervention for 6 months. Before and after intervention, Positive and Negative Syndrome Scale (PANSS), Activity of Daily Living Scale (ADL), Social Disability Screening Schedule (SDSS) and Schizophrenia Quality of Life Scale (SQLS) were used to assess the psychotic symptoms, social function and quality of life in two groups. ResultsAfter intervention, the PANSS total score [(55.54±14.75) vs. (63.52±13.95), t=-2.504, P=0.014], negative symptom factor score [(15.64±4.50) vs. (18.38±5.13), t=-2.547, P=0.013] and general psychopathological factor score [(25.67±7.39) vs. (30.35±6.60), t=-3.015, P=0.003] of the study group were lower than those of the control group. The SDSS score [(8.21±3.78) vs. (10.21±4.67), t=-2.118, P=0.037] and SQLS score [(18.97±6.23) vs. (22.43±8.04), t=2.150, P=0.035] of the study group were lower than those of the control group. ConclusionCommunity rehabilitation combined with drug therapy may help alleviate psychotic symptoms, improve social function and improve quality of life in patients with schizophrenia in rural communities.
7.Systematic evaluation of the therapeutic effect of transcranial direct current stimulation on cognitive function in patients with schizophrenia
Yaju LI ; Jibao DENG ; Yongjie WANG ; Xiaoning HUO ; Xiaolong YANG
Sichuan Mental Health 2024;37(5):482-486
BackgroundDecline in cognitive function is considered a hallmark of schizophrenia, and transcranial direct current stimulation (tDCS) has developed as a promising tool for cognitive enhancement. ObjectiveTo systematically evaluate the effect of tDCS on improving cognitive functioning in patients with schizophrenia, so as to provide references for clinical intervention of cognitive function in patients with schizophrenia. MethodsA computer-based systematic search was conducted on September 12, 2023 through CNKI, Wanfang, VIP, PubMed, CINAHL and PsycINFO databases, and randomized controlled trials relevant to the efficacy of tDCS for management of cognitive function in patients with schizophrenia were collected. The risk of bias was assessed using the Cochrane Risk of Bias Tool for Randomized Trials (RoB 2.0). ResultsA total of 17 articles were included, including 953 patients with schizophrenia. TDCS has an improvement effect on cognitive functions such as information processing speed, attention, working memory, executive function and learning ability in patients with schizophrenia. ConclusiontDCS may have an effect on improving cognitive deficits in patients with schizophrenia. [Funded by Lanzhou Health Science and Technology Development Project (number, 2021024)]